Invalid News Story.
Bioremediation

Bioremediation

The use of bacteria or plants to remove contamination or neutralize polluted soil or water.

News
Showing:  Top Stories  -  Archive
Amgen fell $.47 or .8 percent, to $60.41. Biogen Idec rose $.43 or .9 percent, to $48.59.  
From news.search.yahoo.com via Yahoo News. ()
Related news:
More perspectives...
WORCESTER, Mass., Sept. 5, 2008 -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will present study results at the 44th Annual Meeting of the European Association for the Study of Diabetes to be held in Rome, Italy...  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
Amgen fell $.13 or .2 percent, to $60.75. Biogen Idec fell $.05 or .1 percent, to $48.11.  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
(AP:NEW YORK) Shares of some top biotechnology companies are mixed at 10 a.m.: Amgen rose $.40 or .6 percent, to $62.91. Biogen Idec rose $.06 or .1 percent, to $50.40.  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
"BioTech4U" is the new accompanying program for schoolchildren at Europe's largest biotechnology trade fair BIOTECHNICA held from October 7 through 9, 2008. The youth initiative will be aimed at 12th-grade pupils who are particularly interested in mathematical and natural-science subjects and...  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
Sponsors
Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that Alan H. Auerbach, Chief Executive Officer  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
You can improve this news page by changing its keywords and content sources.
Edit News
Sponsors
Top Science Articles
Mystery Animals: Monsters or Just Terrifying Creatures?
Is the Polar Bears’ Predicament a Sign of Things to Come?
What landed the mighty polar bear on the "threatened" Endangered Species list?
Body Worlds Exhibit
Since its debut in Tokyo in 1996, this show has sparked controversy and curiosity.
More From Zimbio
Copyright © 2008 - Zimbio, Inc. Some rights reserved.